Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

SELL
$5.63 - $8.27 $4,504 - $6,616
-800 Reduced 30.77%
1,800 $12,000
Q2 2023

Jul 18, 2023

SELL
$11.12 - $22.2 $24,464 - $48,840
-2,200 Reduced 45.83%
2,600 $29,000
Q1 2023

May 01, 2023

SELL
$18.7 - $23.07 $409,006 - $504,587
-21,872 Reduced 82.0%
4,800 $96,000
Q4 2022

Feb 07, 2023

BUY
$18.12 - $27.32 $33,703 - $50,815
1,860 Added 7.5%
26,672 $604,000
Q3 2022

Oct 25, 2022

BUY
$16.98 - $25.54 $123,105 - $185,165
7,250 Added 41.28%
24,812 $465,000
Q2 2022

Aug 04, 2022

BUY
$13.15 - $20.45 $13,150 - $20,450
1,000 Added 6.04%
17,562 $327,000
Q1 2022

Apr 14, 2022

SELL
$14.54 - $21.5 $119,228 - $176,300
-8,200 Reduced 33.12%
16,562 $299,000
Q4 2021

Jan 18, 2022

BUY
$20.24 - $36.01 $461,107 - $820,379
22,782 Added 1150.61%
24,762 $513,000
Q3 2021

Oct 26, 2021

SELL
$26.01 - $38.22 $64,192 - $94,326
-2,468 Reduced 55.49%
1,980 $63,000
Q2 2021

Jul 19, 2021

SELL
$29.97 - $37.17 $23,976 - $29,736
-800 Reduced 15.24%
4,448 $136,000
Q1 2021

Apr 26, 2021

BUY
$29.24 - $42.03 $79,825 - $114,741
2,730 Added 108.42%
5,248 $176,000
Q4 2020

Jan 21, 2021

SELL
$35.35 - $50.67 $89,859 - $128,803
-2,542 Reduced 50.24%
2,518 $90,000
Q3 2020

Oct 27, 2020

SELL
$35.98 - $47.66 $757,019 - $1 Million
-21,040 Reduced 80.61%
5,060 $186,000
Q2 2020

Jul 22, 2020

BUY
$45.06 - $67.74 $117,110 - $176,056
2,599 Added 11.06%
26,100 $1.18 Million
Q1 2020

May 07, 2020

BUY
$40.01 - $73.97 $168,001 - $310,600
4,199 Added 21.75%
23,501 $1.12 Million
Q4 2019

Feb 06, 2020

BUY
$37.13 - $74.62 $517,666 - $1.04 Million
13,942 Added 260.11%
19,302 $1.38 Million
Q3 2019

Oct 28, 2019

BUY
$39.36 - $76.8 $120,441 - $235,008
3,060 Added 133.04%
5,360 $210,000
Q2 2019

Aug 09, 2019

SELL
$52.76 - $82.19 $84,416 - $131,504
-1,600 Reduced 41.03%
2,300 $179,000
Q1 2019

May 10, 2019

SELL
$27.39 - $68.41 $498,498 - $1.25 Million
-18,200 Reduced 82.35%
3,900 $232,000
Q4 2018

Feb 05, 2019

SELL
$22.8 - $33.93 $234,634 - $349,173
-10,291 Reduced 31.77%
22,100 $636,000
Q3 2018

Nov 07, 2018

BUY
$29.75 - $43.08 $487,632 - $706,124
16,391 Added 102.44%
32,391 $1.18 Million
Q2 2018

Aug 10, 2018

BUY
$21.96 - $39.94 $220,346 - $400,757
10,034 Added 168.19%
16,000 $604,000
Q1 2018

May 11, 2018

SELL
$17.1 - $26.61 $42,750 - $66,525
-2,500 Reduced 29.53%
5,966 $140,000
Q4 2017

Jan 17, 2018

BUY
$9.47 - $19.59 $78,279 - $161,930
8,266 Added 4133.0%
8,466 $165,000
Q3 2017

Oct 17, 2017

BUY
$7.7 - $9.6 $1,540 - $1,920
200
200 $1,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.